Biocryst Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOCRYST, and what generic alternatives to BIOCRYST drugs are available?
BIOCRYST has two approved drugs.
There are ten US patents protecting BIOCRYST drugs.
There are one hundred and twelve patent family members on BIOCRYST drugs in thirty-seven countries and fifteen supplementary protection certificates in thirteen countries.
Drugs and US Patents for Biocryst
Expired US Patents for Biocryst
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | 6,503,745 | ⤷ Try a Trial |
Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | 6,562,861 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Biocryst Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 102323339 | ⤷ Try a Trial |
Canada | 3164693 | ⤷ Try a Trial |
Netherlands | 301142 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2007117241 | ⤷ Try a Trial |
Australia | 2016262644 | ⤷ Try a Trial |
Japan | 2009533428 | ⤷ Try a Trial |
South Korea | 20230003248 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Biocryst Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3113772 | 21C1048 | France | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT ET SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI; REGISTRATION NO/DATE: EU/1/21/1544 20210504 |
3113772 | 2021C/544 | Belgium | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; AUTHORISATION NUMBER AND DATE: EU/1/21/1544/001 ET 002 20210504 |
3113772 | C03113772/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68464 07.06.2022 |
3113772 | 301142 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/21/1544 20210504 |
3113772 | PA2021524 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTATAS IR JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS ; REGISTRATION NO/DATE: EU/1/21/1544 20210430 |
3113772 | 132021000000164 | Italy | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT E SUOI SALI FARMACEUTICAMENTE ACCETTABILI(ORLADEYO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/21/1544/001-002, 20210504 |
3113772 | LUC00233 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT ET LES SELS PHARMACEUTIQUEMENT ACCEPTABLES QUI EN DERIVENT; AUTHORISATION NUMBER AND DATE: EU/1/21/1544 20210504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.